140 related articles for article (PubMed ID: 10853025)
1. Detection of c-erbB-2 and FGF-3 (INT-2) gene amplification in epithelial ovarian cancer.
Seki A; Yoshinouchi M; Seki N; Kodama J; Miyagi Y; Kudo T
Int J Oncol; 2000 Jul; 17(1):103-6. PubMed ID: 10853025
[TBL] [Abstract][Full Text] [Related]
2. Detection of c-erbB-2/neu and fibroblast growth factor-3/INT-2 but not epidermal growth factor receptor gene amplification in endometrial cancer by differential polymerase chain reaction.
Esteller M; García A; Martínez i Palones JM; Cabero A; Reventós J
Cancer; 1995 Apr; 75(8):2139-46. PubMed ID: 7697605
[TBL] [Abstract][Full Text] [Related]
3. DNA amplification of HER-2/neu and INT-2 oncogenes in epithelial ovarian cancer.
Medl M; Sevelda P; Czerwenka K; Dobianer K; Hanak H; Hruza C; Klein M; Leodolter S; Müllauer-Ertl S; Rosen A
Gynecol Oncol; 1995 Dec; 59(3):321-6. PubMed ID: 8522248
[TBL] [Abstract][Full Text] [Related]
4. Amplification of c-erbB-2, int-2 and c-myc genes in node-negative breast carcinomas. Relationship to prognosis.
Ottestad L; Andersen TI; Nesland JM; Skrede M; Tveit KM; Nustad K; Børresen AL
Acta Oncol; 1993; 32(3):289-94. PubMed ID: 8100712
[TBL] [Abstract][Full Text] [Related]
5. First experience with FGF-3 (INT-2) amplification in women with epithelial ovarian cancer.
Rosen A; Sevelda P; Klein M; Dobianer K; Hruza C; Czerwenka K; Hanak H; Vavra N; Salzer H; Leodolter S
Br J Cancer; 1993 May; 67(5):1122-5. PubMed ID: 8494710
[TBL] [Abstract][Full Text] [Related]
6. Int-2/FGF3 amplification is a better independent predictor of relapse than c-myc and c-erbB-2/neu amplifications in primary human breast cancer.
Champème MH; Bièche I; Hacène K; Lidereau R
Mod Pathol; 1994 Dec; 7(9):900-5. PubMed ID: 7892157
[TBL] [Abstract][Full Text] [Related]
7. HER-2 and INT-2 amplification estimated by quantitative PCR in paraffin-embedded ovarian cancer tissue samples.
Hruza C; Dobianer K; Beck A; Czerwenka K; Hanak H; Klein M; Leodolter S; Medl M; Müllauer-Ertl S; Preiser J
Eur J Cancer; 1993; 29A(11):1593-7. PubMed ID: 8105839
[TBL] [Abstract][Full Text] [Related]
8. Oncogenic potential of c-erbB-2 and its association with c-K-ras in premalignant and malignant lesions of the human uterine endometrium.
Manavi M; Bauer M; Baghestanian M; Berger A; Kucera E; Pischinger K; Battistutti W; Czerwenka K
Tumour Biol; 2001; 22(5):299-309. PubMed ID: 11553860
[TBL] [Abstract][Full Text] [Related]
9. Activation of c-erbB-2 and prognosis in ovarian carcinoma. Comparison with histologic type, grade, and stage.
Singleton TP; Perrone T; Oakley G; Niehans GA; Carson L; Cha SS; Strickler JG
Cancer; 1994 Mar; 73(5):1460-6. PubMed ID: 7906608
[TBL] [Abstract][Full Text] [Related]
10. Gene amplification of int-2 and erbB in human esophageal cancer: relationship to clinicopathological variables.
Suzuki H; Abo S; Kitamura M; Hashimoto M; Izumi K; Terada K; Sugiyama T
Cancer Invest; 1997; 15(5):411-5. PubMed ID: 9316622
[TBL] [Abstract][Full Text] [Related]
11. [The significance of c-erbB-2 and int-2 gene alterations and DNA ploidy pattern for aggressiveness of breast cancer].
Nagayama K; Watatani M; Maeda S; Imanishi Y; Kurooka K; Wada T; Yasutomi M
Nihon Geka Gakkai Zasshi; 1993 Oct; 94(10):1144-52. PubMed ID: 7901748
[TBL] [Abstract][Full Text] [Related]
12. Amplification of the C-erbB-2(HER-2/neu) proto-oncogene in ovarian carcinomas.
Fan QB; Bian ML; Huang SZ; Lang JH; Ma J; Liu WS; Xu XY
Chin Med J (Engl); 1994 Aug; 107(8):589-93. PubMed ID: 7805442
[TBL] [Abstract][Full Text] [Related]
13. Protooncogene amplification and tumor ploidy in human ovarian neoplasms.
Sasano H; Garrett CT; Wilkinson DS; Silverberg S; Comerford J; Hyde J
Hum Pathol; 1990 Apr; 21(4):382-91. PubMed ID: 1969381
[TBL] [Abstract][Full Text] [Related]
14. A prospective study of the significance of gene and chromosome alterations as prognostic indicators of breast cancer patients with lymph node metastases.
Tsuda H; Sakamaki C; Tsugane S; Fukutomi T; Hirohashi S
Breast Cancer Res Treat; 1998 Mar; 48(1):21-32. PubMed ID: 9541186
[TBL] [Abstract][Full Text] [Related]
15. c-erbB2 gene amplification and protein expression in ovarian epithelial tumors: evaluation of their respective prognostic significance by multivariate analysis.
Fajac A; Benard J; Lhomme C; Rey A; Duvillard P; Rochard F; Bernaudin JF; Riou G
Int J Cancer; 1995 Apr; 64(2):146-51. PubMed ID: 7615357
[TBL] [Abstract][Full Text] [Related]
16. [int-2 and c-erbB-2 gene amplification in urological cancers].
Sato K; Kato T; Moriyama M
Nihon Hinyokika Gakkai Zasshi; 1992 Dec; 83(12):1957-63. PubMed ID: 1361954
[TBL] [Abstract][Full Text] [Related]
17. [The relation between prognosis and amplification of the c-erB-2 (HER-2/neu) proto-oncogene in ovarian carcinomas].
Fan QB; Bian ML; Huang SZ
Zhonghua Yi Xue Za Zhi; 1994 Nov; 74(11):683-5, 710. PubMed ID: 7866905
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of the oncogene c-erbB-2 (HER2/neu) in ovarian cancer: a new prognostic factor.
Meden H; Kuhn W
Eur J Obstet Gynecol Reprod Biol; 1997 Feb; 71(2):173-9. PubMed ID: 9138962
[TBL] [Abstract][Full Text] [Related]
19. Amplification of the c-erbB-2 gene in gastric carcinoma: correlation with survival.
Tsugawa K; Fushida S; Yonemura Y
Oncology; 1993; 50(6):418-25. PubMed ID: 7901825
[TBL] [Abstract][Full Text] [Related]
20. Meanings of c-erbB and int-2 amplification in superficial esophageal squamous cell carcinomas.
Ikeda Y; Ozawa S; Ando N; Kitagawa Y; Ueda M; Kitajima M
Ann Thorac Surg; 1996 Sep; 62(3):835-8. PubMed ID: 8784015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
